Drugs News and Research

RSS

Death of a 43-year-old male marks the entry of 'zombie' drug into the UK

The death of a 43-year-old male is the first in the UK to be associated with Xylazine and marks the entry of the drug into the UK drug supply.

26 May 2023

Kentucky, Michigan scientists receive American Heart Association Merit Award for cardiovascular research

A Lexington, Ky., research scientist studying ways to repair damaged major vessels with medication rather than surgery and a physician-scientist from Ann Arbor, Mich., exploring the mechanisms of how exercise can heal heart muscle and brain tissue following a heart attack or stroke are the most recent American Heart Association Merit Award recipients.

26 May 2023

Markey one of 71 NCI designated cancer centers in the U.S.

When the University of Kentucky Markey Cancer Center earned a designation the National Cancer Institute (NCI) in 2013, it instantly established Markey as one of the top cancer research centers in the U.S.

26 May 2023

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Pittsburgh Analytical Chemistry Award, Neil Kelleher, about his work in top-down proteinomics.

From Pittcon 26 May 2023

Do glucose-lowering medications have different effects on kidney outcomes?

Researchers evaluated the kidney outcomes in individuals with type 2 diabetes.

26 May 2023

Study reveals type 2 diabetes diagnosis spurs cholesterol shifts, alters cardiovascular risk

A recent study published in the journal Scientific Reports assessed the associations between the change in total cholesterol (TC) levels after type 2 diabetes (T2D) diagnosis (relative to pre-diagnosis levels) and the risk of cardiovascular disease (CVD).

26 May 2023

Scientists use AI to identify new antibiotic that could fight drug-resistant infections

Using an artificial intelligence algorithm, researchers at MIT and McMaster University have identified a new antibiotic that can kill a type of bacteria that is responsible for many drug-resistant infections.

25 May 2023

Tumors in distant organs remotely reprogram the liver

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from investigators at Weill Cornell Medicine.

25 May 2023

Antiviral drugs may be a new treatment strategy in the fight against Candida auris

Antiviral drugs can make antifungals work again.

25 May 2023

Adoption of Mediterranean diet shows promise in easing symptoms for myeloproliferative neoplasm patients

Researchers assess the feasibility of an education-focused Mediterranean diet intervention among myeloproliferative neoplasm patients.

25 May 2023

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease

In a noteworthy case study published in the Journal of Alzheimer's Disease investigators report autopsy findings in a 65-year-old woman with Alzheimer's disease (AD) who received three open label infusions of the experimental anti-amyloid beta (Aβ) antibody drug lecanemab.

25 May 2023

Alzheimer’s development: Study reveals why apoE4 gene fails to protect the brain from inflammation

A possible explanation has been found in a study for why apoE4, the most significant genetic risk factor associated with Alzheimer's disease, fails to protect the brain from inflammation.

25 May 2023

The first thousand days of development

Study provides a bird's-eye view of the significant moments of the first thousand days of life.

25 May 2023

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Catherine Reitzel's multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies on a drug for a blood-clotting disorder that runs $10,000 for a three-day supply. And Mariana Marquez-Farmer would likely die within days without her monthly $300 vial of insulin.

25 May 2023

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

In this behind-the-scenes interview, we speak to Dr. Sinead Knight, chair of SLAS Europe 2023, about this years programme, highlighting the key topics and speakers.

From Society for Laboratory Automation and Screening (SLAS) 25 May 2023

Researchers disclose how a nanomachine takes care of cleaning up inside the cell

To prevent our body's cells from overflowing with garbage and to keep them healthy, the waste inside them is constantly being disposed of.

25 May 2023

Common diabetes drug could be repurposed as a treatment for autoimmune disorders

Swansea University researchers have found that a drug commonly used to treat type 2 diabetes can potentially be used in the treatment of autoimmune disorders.

25 May 2023

Examining first treatment for strokes linked to dementia

People who experience a type of stroke linked with nearly half of all dementias could be treated for the first time by repurposing two cheap and common drugs, a trial shows.

25 May 2023

New class of tiny, self-propelled robots could one day deliver drugs throughout the human body

A team of engineers at the University of Colorado Boulder has designed a new class of tiny, self-propelled robots that can zip through liquid at incredible speeds - and may one day even deliver prescription drugs to hard-to-reach places inside the human body.

24 May 2023

Researchers use AI models to advance drug delivery system for chronic eye diseases

Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

24 May 2023

Drugs News and Research

Death of a 43-year-old male marks the entry of 'zombie' drug into the UK

Kentucky, Michigan scientists receive American Heart Association Merit Award for cardiovascular research

Markey one of 71 NCI designated cancer centers in the U.S.

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Do glucose-lowering medications have different effects on kidney outcomes?

Study reveals type 2 diabetes diagnosis spurs cholesterol shifts, alters cardiovascular risk

Scientists use AI to identify new antibiotic that could fight drug-resistant infections

Tumors in distant organs remotely reprogram the liver

Antiviral drugs may be a new treatment strategy in the fight against Candida auris

Adoption of Mediterranean diet shows promise in easing symptoms for myeloproliferative neoplasm patients

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease

Alzheimer’s development: Study reveals why apoE4 gene fails to protect the brain from inflammation

The first thousand days of development

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

Researchers disclose how a nanomachine takes care of cleaning up inside the cell

Common diabetes drug could be repurposed as a treatment for autoimmune disorders

Examining first treatment for strokes linked to dementia

New class of tiny, self-propelled robots could one day deliver drugs throughout the human body

Researchers use AI models to advance drug delivery system for chronic eye diseases

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News